Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: a cohort study

NJ Patel, X Wang, X Fu, Y Kawano, C Cook… - Seminars in arthritis and …, 2023 - Elsevier
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
被引用次数：27 相关文章

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study

NJ Patel, X Wang, X Fu, Y Kawano… - … in arthritis and …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.

NJ Patel, X Wang, X Fu, Y Kawano, C Cook… - Seminars in Arthritis …, 2022 - europepmc.org
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …
[HTML] nih.gov

[HTML][HTML] Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study

NJ Patel, X Wang, X Fu, Y Kawano… - Seminars in Arthritis …, 2023 - ncbi.nlm.nih.gov
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.

NJ Patel, X Wang, X Fu, Y Kawano, C Cook… - Seminars in Arthritis …, 2022 - europepmc.org
Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …